Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E

2011/08/23 by Francesca Fiory, F. Fiory, Assunta Lombardi +9 · 27 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · #Advanced Glycation End Products research #Aldose Reductase and Taurine #Beta cell #Biochemistry #Biology #Chemistry #Endocrinology #Enzyme #Glucose uptake #Glycogen synthase #Insulin #Insulin receptor #Insulin resistance #Internal medicine #Islet #Medicine #Methylglyoxal #Pancreatic function and diabetes #Protein kinase B #Receptor #Signal transduction #Tyrosine phosphorylation

paper · pdf · doi:10.1007/s00125-011-2280-8

openalex publication_date 2011/08/23 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises
• The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases
• Glycation and insulin resistance: novel mechanisms and unique targets? [europepmc]
• Semiquantitative analysis of apolipoprotein A-I modified by advanced glycation end products in diabetes mellitus. [europepmc]
• Methylglyoxal induces platelet hyperaggregation and reduces thrombus stability by activating PKC and inhibiting PI3K/Akt pathway. [europepmc]
• Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial. [europepmc]
• Methylglyoxal induces mitochondrial dysfunction and cell death in liver. [europepmc]
• Is vitamin D deficiency related to accumulation of advanced glycation end products, markers of inflammation, and oxidative stress in diabetic subjects? [europepmc]
• Methylglyoxal Impairs Insulin Secretion of Pancreatic β-Cells through Increased Production of ROS and Mitochondrial Dysfunction Mediated by Upregulation of UCP2 and MAPKs. [europepmc]
• Methylglyoxal-Glyoxalase 1 Balance: The Root of Vascular Damage. [europepmc]
• Effects of Two Different Dietary Patterns on Inflammatory Markers, Advanced Glycation End Products and Lipids in Subjects without Type 2 Diabetes: A Randomised Crossover Study. [europepmc]
• Methylglyoxal-induced glycation changes adipose tissue vascular architecture, flow and expansion, leading to insulin resistance. [europepmc]
• Dicarbonyl stress and glyoxalase enzyme system regulation in human skeletal muscle. [europepmc]
• Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure. [europepmc]
• Sirolimus induces depletion of intracellular calcium stores and mitochondrial dysfunction in pancreatic beta cells. [europepmc]
• The Expression of Aldolase B in Islets Is Negatively Associated With Insulin Secretion in Humans. [europepmc]
• Ameliorating Methylglyoxal-Induced Progenitor Cell Dysfunction for Tissue Repair in Diabetes. [europepmc]
• The combination of loss of glyoxalase1 and obesity results in hyperglycemia. [europepmc]
• Dicarbonyl Stress at the Crossroads of Healthy and Unhealthy Aging. [europepmc]
• Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease. [europepmc]
• Arginine and Endothelial Function. [europepmc]
• Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction. [europepmc]
• Glycation of Tie-2 Inhibits Angiopoietin-1 Signaling Activation and Angiopoietin-1-Induced Angiogenesis. [europepmc]
• The m 6 A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA Expression. [europepmc]
• L-Arginine in diabetes: clinical and preclinical evidence. [europepmc]
• Methylglyoxal in Cardiometabolic Disorders: Routes Leading to Pathology Counterbalanced by Treatment Strategies. [europepmc]
• A Comprehensive Review of Metabolic Dysfunction-Associated Steatotic Liver Disease: Its Mechanistic Development Focusing on Methylglyoxal and Counterbalancing Treatment Strategies. [europepmc]